Charles Conway serves as Executive at Biohaven Pharmaceutical Holding Co Ltd., where they oversee executive responsibilities. Since joining the company, Charles Conway has executed 14 insider transactions totaling $356.6K, demonstrating a bearish approach to their equity position. Their most recent transaction on Oct 3, 2022 involved selling 22,362 shares valued at $3.3M.
Charles Conway currently holds 22,135 shares of Biohaven Pharmaceutical Holding Co Ltd. (BHVN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Charles Conway has been a net seller of BHVN stock. They have purchased $68.0K and sold $288.6K worth of shares.
Charles Conway's most recent insider trade was on Oct 3, 2022, when they sold 22,362 shares at $148.50 per share.
Get notified when new Form 4 filings are submitted
| 1,800 |
| $123.86 |
| Discretionary |
| Jan 6, 2022 | BHVN | $0 | Option Exercise | 3,750 | $N/A | Discretionary |
| Nov 25, 2021 | BHVN | $0 | Option Exercise | 3,000 | $N/A | Discretionary |
| Nov 23, 2021 | BHVN | $375.4K | Option Exercise | 10,000 | $37.54 | Discretionary |
| Nov 23, 2021 | BHVN | $18.4K | Option Exercise | 885 | $20.79 | Discretionary |
| Jan 6, 2021 | BHVN | $145.7K | Payment | 1,747 | $83.38 | Discretionary |
| Jan 6, 2021 | BHVN | $0 | Option Exercise | 3,750 | $N/A | Discretionary |
| Nov 25, 2020 | BHVN | $122.7K | Payment | 1,361 | $90.14 | Discretionary |
| Nov 25, 2020 | BHVN | $0 | Option Exercise | 3,000 | $N/A | Discretionary |
| Jun 17, 2020 | BHVN | $288.6K | Sale | 4,000 | $72.15 | Discretionary |
| Dec 18, 2019 | BHVN | $70.9K | Payment | 1,361 | $52.13 | Discretionary |
| Dec 18, 2019 | BHVN | $0 | Option Exercise | 3,000 | $N/A | Discretionary |
| May 9, 2017 | BHVN | $68.0K | Purchase | 4,000 | $17.00 | Discretionary |